Corvus Pharmaceuticals's total assets for Q1 2025 were $59.44M, a decrease of -13.74% from the previous quarter. CRVS total liabilities were $10.11M for the fiscal quarter, a -72.17% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.